toosendanin has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Li, Y; Wang, G; Zhang, LH | 1 |
1 other study(ies) available for toosendanin and Cancer of Ovary
| Article | Year |
|---|---|
Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Female; Humans; MicroRNAs; Ovarian Neoplasms | 2023 |